Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · IEX Real-Time Price · USD
3.220
-0.040 (-1.23%)
At close: Jul 2, 2024, 4:00 PM
3.290
+0.070 (2.17%)
After-hours: Jul 2, 2024, 6:42 PM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $366.54 million as of July 2, 2024. Its market cap has decreased by -25.20% in one year.
Market Cap
366.54M
Enterprise Value
69.89M
1-Year Change
-25.20%
Ranking
Category
Stock Price
$3.22
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $366.54M, an increase of 190.67%. That is a compound annual growth rate of 10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 366.50M | -0.62% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ModivCare | 384.55M |
| Anika Therapeutics | 384.06M |
| Daré Bioscience | 383.14M |
| Editas Medicine | 379.12M |
| Cabaletta Bio | 377.04M |
| Emergent BioSolutions | 369.96M |
| Bioventus | 365.73M |
| Aura Biosciences | 365.13M |